Proceedings of the Trans Atlantic Reproductive Technologies Network [TARTEN2011]

Macklon NS Stouffer RL Giudice L Fauser BCJM . The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006 Apr;27(2): 170–207.

Fauser BC Nargund G Andersen AN Norman R Tarlatzis B Boivin J Ledger W . Mild ovarian stimulation for IVF: 10 years later. Hum Reprod. 2010 Nov;25(11): 2678–84.

Humaidan P Bredkjaer HE Bungum L Bungum M Grondahl ML Westergaard L Andersen CY . GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005: 20; 1213–1220.

Humaidan P Bungum L Bungum M Yding Andersen C . Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006: 13; 173–178.

Humaidan P . Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod Biomed Online 2009b: 18; 630–634.

Humaidan P Papanikolaou EG Tarlatzis BC . GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod 2009c: 24; 2389–2394.

Humaidan P Ejdrup Bredkjaer H Westergaard LG Yding Andersen C . 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 2010: 93; 847–854.

Simoni M Nieschlag E Gromoll J . Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update. 2002 Sep-Oct;8(5): 413–21.

Gromoll J Simoni M . Genetic complexity of FSH receptor function. Trends Endocrinol Metab. 2005 Oct; 16(8): 368–73.

Ahda Y Gromoll J Wunsch A Asatiani K Zitzmann M Nieschlag E Simoni M . J Androl. Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. 2005 Jul-Aug;26(4): 494–9.

Wunsch A Ahda Y Banaz-Yaşar F Sonntag B Nieschlag E Simoni M Gromoll J . Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril. 2005 Aug;84(2): 446–53.

Baird DT . A model for follicular selection and ovulation: lessons from superovulation. J. Steroid Biochem. 1987;27(1–3):15–23.

Brown JB . Pituitary control of ovarian function-concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol. 1978 Feb;18(1): 46–54.

Schipper I Hop WCJ Fauser BCJM . The Follicle-Stimulating Hormone (FSH) Threshold/Window Concept Examined by Different Interventions with Exogenous FSH during the Follicular Phase of the Normal Menstrual Cycle: Duration, Rather Than Magnitude, of FSH Increase Affects Follicle Development. J Clin Endocrinol Metab. 1998 Apr 1;83(4): 1292–1298.

Perez Mayorga M Gromoll J Behre HM Gassner C Nieschlag E Simoni M . Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 2000 Set;85(9): 3365–3369.

Zheng W Magid M Kramer E Chen Y . Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol. 1996 Gen 1; 148(1): 47–53.

Greb RR Grieshaber K Gromoll J Sonntag B Nieschlag E Kiesel L A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J. Clin. Endocrinol. Metab. 2005 Ago;90(8): 4866–4872.

Gromoll J Simoni M . Genetic complexity of FSH receptor function. Trends Endocrinol. Metab. 2005 Ott;16(8): 368–373.

Loutradis D Vlismas A Drakakis P Antsaklis A . Pharmacogenetics in ovarian stimulation–current concepts. Ann. N. Y. Acad. Sci. 2008 Apr;1127:10–19.

Behre HM Greb RR Mempel A Sonntag B Kiesel L Kaltwasser P Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet. Genomics. 2005 Lug;15(7): 451–456.

Jun JK Yoon JS Ku S Choi YM Hwang KR Park SY Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J. Hum. Genet. 2006;51(8): 665–670.

Klinkert ER Velde ER Weima S van Zandvoort PM Hanssen RGJM Nilsson PR FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod. Biomed. Online. 2006 Nov;13(5): 687–695.

Meyer JM Eaves LJ Heath AC Martin NG . Estimating genetic influences on the age-atmenarche: a survival analysis approach. Am. J. Med. Genet. 1991 Mag 1;39(2): 148–154.

Kaprio J Rimpelä A Winter T Viken RJ Rimpelä M Rose RJ . Common genetic influences on BMI and age at menarche. Hum. Biol. 1995 Ott;67(5): 739–753.

Zerbetto I Gromoll J Luisi S Reis FM Nieschlag E Simoni M Follicle stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause. Fertil. Steril. 2008 Dic;90(6): 2264–2268.

Morón FJ Ruiz A . Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers. Pharmacogenomics. 2010 Nov;11(11): 1613–8.

Achrekar SK Modi DN Desai SK Mangoli VS Mangoli RV Mahale SD . Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod. Biomed. Online. 2009 Apr;18(4): 509–515.

Ochsenkühn R von Schönfeldt V Simoni M . FSH receptor polymorphisms and ovarian function. Texte intégral de l'article Printable version FSH receptor polymorphisms and ovarian function MT / médecine de la reproduction, gynécologie et endocrinologie. 2009 Ago;11(4): 265–270.

Johnson J Canning J Kaneko T Pru JK Tilly JL (2004) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428:145–150.

Niikura Y Niikura T Tilly JL (2009) Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment. Aging 1:971–978.

Pacchiarotti J Maki C Ramos T Marh J Howerton K Wong J Pham J Anorve S Chow Y-C Izadyar F (2010) Differentiation potential of germ line stem cells derived from the postnatal mouse ovary. Differentiation 79:159–170.

Tilly JL Telfer EE (2009) Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock? Mol Hum Reprod 15:393–398.

Tilly JL Niikura Y Rueda BR (2009) The current status of evidence for and against postnatal oogenesis in mammals: a case of ovarian optimism versus pessimism? Biol Reprod 80:2–12.

Wang N Tilly JL (2010) Epigenetic status determines germ cell meiotic commitment in embryonic and postnatal mammalian gonads. Cell Cycle 9:339–349.

Zou K Yuan Z Yang Z Luo H Sun K Zhou L Xiang J Shi L Yu Q Zhang Y Hou R Wu J (2009) Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol 11:631–636.

Schmidt KT Larsen EC Andersen CY Andersen AN . Risk of ovarian failure and fertility preserving methods in girls and adolescents with a malignant disease 2010 BJOG Jan; 117(2): 163–74.

Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853–861.

Knochenhauer ES Key TJ Kahsar-Miller M Waggoner W Boots LR Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078–3082.

Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223–1236.

Robinson S Chan SP Spacey S Anyaoku V Johnston DG Franks S 1992 Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf) 36:537–543.

Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. EndocrRev 18:774–800.

Dahlgren E Johansson S Lindstedt G Knutsson F Oden A Janson PO Mattson LA Crona N Lundberg PA 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505–513.

Wild S Pierpoint T Jacobs H McKeigue P 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 3:101–105.

Solomon CG Hu FB Dunaif A Rich-Edwards JE Stampfer MJ Willett WC Speizer FE Manson JE 2002 Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87:2013–2017.

Legro RS Kunselman AR Dodson WC Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165–169.

Ehrmann DA Barnes RB Rosenfield RL Cavaghan MK Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141–146.

Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505–22.

Rausch ME Legro RS Barnhart HX Schlaff WD Carr BR Diamond MP Carson SA Steinkampf MP McGovern PG Cataldo NA Gosman GG Nestler JE Giudice LC Leppert PC Myers ER Coutifaris C ; Reproductive Medicine Network Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:3458–66.

Mulders AG Eijkemans MJ Imani B Fauser BC . Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online. 2003;7:170–8.

Eijkemans MJ Imani B Mulders AG Habbema JD Fauser BC . High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod. 2003;18(2357–62.

Eijkemans MJ Polinder S Mulders AG Laven JS Habbema JD Fauser BC . Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2) Human Reprod 2005;20:2830–7.

Farquhar C Lilford RJ Marjoribanks J Vandekerckhove P . Laparoscopic ‘drilling’ by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database SystRev. 2007, 18;(3):CD001122.

Tso LO Costello MF Albuquerque LE Andriolo RB Freitas V . Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006105.

Boomsma CM Fauser BC Macklon NS . Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med. 2008 Jan;26(1): 72–84.